A growing number of Medicaid managed-care insurers have received approval from state regulators and state insurance exchange officials to enroll non-Medicaid members on the exchanges in October, marking the first time these specialized insurers will offer health coverage to the general public.
A growing number of Medicaid managed-care insurers have received approval from state regulators and state insurance exchange officials to enroll non-Medicaid members on the exchanges in October, marking the first time these specialized insurers will offer health coverage to the general public.
These insurers are rolling out new plans that meet the benefit and other requirements of the exchanges, which were established by the Patient Protection and Affordable Care Act. Some also will be selling non-Medicaid plans outside the exchanges.
Read the full story: http://bit.ly/1aSDfCt
Source: Modern Healthcare
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More